Discontinued — last reported Q3 '22
HCA Healthcare Acquisitions increased by 2.9% to $36.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 14.3%, from $42.00M to $36.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -22.6% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $76.00M | $390.00M | $617.00M | $2.00M | $114.00M | $60.00M | $48.00M | $115.00M | $9.00M | $157.00M | $354.00M | $96.00M | $35.00M | $93.00M | $42.00M | $227.00M | $99.00M | $35.00M | $36.00M |
| QoQ Change | — | +413.2% | +58.2% | -99.7% | >999% | -47.4% | -20.0% | +139.6% | -92.2% | >999% | +125.5% | -72.9% | -63.5% | +165.7% | -54.8% | +440.5% | -56.4% | -64.6% | +2.9% |
| YoY Change | — | — | — | — | +50.0% | -84.6% | -92.2% | >999% | -92.1% | +161.7% | +637.5% | -16.5% | +288.9% | -40.8% | -88.1% | +136.5% | +182.9% | -62.4% | -14.3% |